Foster City, CA, United States of America

Frederic J De Sauvage

USPTO Granted Patents = 45 (Patent Applications = 23)

CIPO Patents = 3 (Patent Applications = 6)

EPO Patents = 12 (Patent Applications = 11)

Average Co-Inventor Count = 2.9

ph-index = 8

Forward Citations = 175(Granted Patents)

Company Filing History:

Assistance Publique-hopitaux De Paris

patents

5. 1 out of 103

Université Paris Diderot-Paris 7

patents

6. 1 out of 1,579

Washington University

patents

where one patent can have more than one assignee

Years Active: 1998-2019

Loading Chart...

45 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 10330683 - Mutant smoothened and methods of using the same (2019-06-25),

2. 10246515 - Methods of treating hedgehog-related diseases with an anti-LGR5 antibody (2019-04-02),

3. 9910050 - Mutant smoothened and methods of using the same (2018-03-06),

4. 9321823 - Mutant smoothened and methods of using the same (2016-04-26),

5. 9096686 - E518A/K mutant smoothened and methods of using the same (2015-08-04),

6. 9085630 - Compositions and methods for the treatment of tumor of hematopoietic origin (2015-07-21),

7. 8481680 - Mutant smoothened and methods of using the same (2013-07-09),

8. 8435754 - Method of diagnosing the presence of a tumor in a mammal by assessing CDO expression levels (2013-05-07),

9. 8399250 - [object Object] (2013-03-19),

10. 8394939 - Nucleic acid encoding fused (2013-03-12),

11. 8388973 - Compositions and methods for the treatment of tumor of hematopoietic origin (2013-03-05),

12. 8357513 - [object Object] (2013-01-22),

13. 8278099 - Monoclonal antibody to human thrombopoietin (2012-10-02),

14. 8241900 - [object Object] (2012-08-14),

15. 8193323 - [object Object] (2012-06-05),

As an AI assistant specializing in innovations, inventions, inventors, patent attorneys, assignees, and patents, I can provide you with information about inventor Frederic J De Sauvage.

Title: Innovator Spotlight: Frederic J De Sauvage

Introduction:

Frederic J De Sauvage is a renowned inventor based in Foster City, CA (US) known for his significant contributions in the field of medical research and pharmaceuticals. With an impressive portfolio of 36 patents, De Sauvage has been instrumental in developing cutting-edge technologies and treatments.

Latest Patents:

One of his latest patents includes "Mutant smoothened and methods of using the same" which focuses on mutations in the serpentine receptor, Smoothened (SMO), leading to drug resistance in cancer treatment. Another groundbreaking patent is "Methods of treating hedgehog-related diseases with an anti-LGR5 antibody" aimed at treating hedgehog-related diseases like basal cell carcinoma.

Career Highlights:

Frederic J De Sauvage has made significant contributions during his tenure at companies like Genentech, Inc. and Curis, Inc. His innovative approach and expertise have played a crucial role in advancing the field of biotechnology and pharmaceuticals.

Collaborations:

Throughout his career, De Sauvage has collaborated with esteemed professionals in the industry, including Dan L Eaton and Arnon Rosenthal. These collaborations have led to the development of novel treatments and technologies that have had a positive impact on healthcare.

Conclusion:

In conclusion, Frederic J De Sauvage stands out as a pioneering inventor in the field of medical research and pharmaceuticals. His numerous patents, collaborations, and career achievements highlight his dedication to innovation and improving healthcare outcomes.

This text is generated by artificial intelligence and may not be accurate.